JPS5938946B2 - Method for producing hydroquinone compounds - Google Patents

Method for producing hydroquinone compounds

Info

Publication number
JPS5938946B2
JPS5938946B2 JP53102647A JP10264778A JPS5938946B2 JP S5938946 B2 JPS5938946 B2 JP S5938946B2 JP 53102647 A JP53102647 A JP 53102647A JP 10264778 A JP10264778 A JP 10264778A JP S5938946 B2 JPS5938946 B2 JP S5938946B2
Authority
JP
Japan
Prior art keywords
formula
reaction
compound
solution
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53102647A
Other languages
Japanese (ja)
Other versions
JPS5528960A (en
Inventor
芳司 藤田
孝志 大西
卓司 西田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Original Assignee
Kuraray Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd filed Critical Kuraray Co Ltd
Priority to JP53102647A priority Critical patent/JPS5938946B2/en
Publication of JPS5528960A publication Critical patent/JPS5528960A/en
Publication of JPS5938946B2 publication Critical patent/JPS5938946B2/en
Expired legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

【発明の詳細な説明】 本発明は、ビタミンK類、補酵素Q類、ポリプレニルト
リメチルキノン類の合成中間体として有用な新規なハイ
ドロキノン系化合物およびその製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel hydroquinone compound useful as a synthetic intermediate for vitamin K, coenzyme Q, and polyprenyltrimethylquinone, and a method for producing the same.

ビタミンK2、ポリプレニルトリメチルキノン類、補酵
素Q等のイソプレン骨格を有するキノン類は医薬として
重要な位置を占めている。
Quinones having an isoprene skeleton, such as vitamin K2, polyprenyltrimethylquinones, and coenzyme Q, occupy an important position as medicines.

※〔nはイソプレン単位の数を表わす〕 上記式においてnが1〜約12のものは天然に存在して
いるが、薬理活性上特に重要とされているのは、補酵素
Qについてはnが7〜12のもの、ポリプレニルトリメ
チルキノン類についてはnが4のもの、ビタミンK2に
ついてはnが4以上のものである。
* [n represents the number of isoprene units] In the above formula, those where n is 1 to about 12 exist naturally, but what is considered to be particularly important from the viewpoint of pharmacological activity is that for coenzyme Q, where n is For polyprenyltrimethylquinones, n is 4, and for vitamin K2, n is 4 or more.

これらの化合物の二重結合の立体化学に関しては全トラ
ンス体が好ましいとされている。このようなキノン類を
合成的に製造する方法として、補酵素Qを例にとれば、
2・3−ジメトキシ−5−メチルハイドロキノン(母核
)にプレニルアルコールもしくはその誘導体を反応させ
、得られる縮合反応生成物を酸化して対応するキiノン
としたのち精製(シス体分離)する方法が比較的古くか
ら知られている(たとえば特公昭38−26372号、
同39−17513号、同46−3967号)。
Regarding the stereochemistry of the double bond in these compounds, all-trans isomers are preferred. Taking coenzyme Q as an example, as a method for synthetically producing such quinones,
A method in which 2,3-dimethoxy-5-methylhydroquinone (mother nucleus) is reacted with prenyl alcohol or its derivatives, the resulting condensation reaction product is oxidized to the corresponding quinone, and then purified (cis-isomer separation) has been known for a relatively long time (for example, Special Publication No. 38-26372,
39-17513, 46-3967).

反応は次式で示される。The reaction is shown by the following formula.

フ ッ 上記の縮合反応は酸性触媒たとえばギ酸、硫酸、塩酸、
リン酸、p−トルエンスルホン酸等のプロトン酸、塩化
亜鉛、塩化アルミニウム、三弗化ホウ素エーテル錯体等
のルイス酸の存在下で行うことができるが、ポリプレニ
ル側鎖内での閉環、縮合反応生成物のクロマン環形成等
の副反応が生じるため、目的物の収率は高くとも30%
である。
The above condensation reaction with fluorine is carried out using acidic catalysts such as formic acid, sulfuric acid, hydrochloric acid,
This can be carried out in the presence of a protonic acid such as phosphoric acid or p-toluenesulfonic acid, or a Lewis acid such as zinc chloride, aluminum chloride, or boron trifluoride ether complex, but ring closure and condensation reactions within the polyprenyl side chain can be carried out. Because side reactions such as chroman ring formation occur, the yield of the target product is at most 30%.
It is.

この欠点を改善するために母核形成物質として2・3−
ジメトキシ−5−メチルハイドロキノンジメトキシメチ
ルエーテル−6−マグネシウムハライドを用い、これに
ポリプレニルハロゲン化物のπアリル型ニツケル錯体を
反応させるか、または触媒としての塩化パラジウムもし
くはジクロルビス−(トリフエニルホスフイン)−ニツ
ケルの存在下ポリプレニル・・ロゲン化物を反応させる
方法(特開昭51−11723号、同51−11724
号)、2・3−ジメトキシ−5−メチル−6−ハロゲノ
ハイドロキノンジアセテートを母核形成物質としてポリ
プレニルハロゲン化物のπ−アリル型ニツケル錯体を反
応させる方法(特開昭48一85546号、同50−5
8021号)、2・3−ジメトキシ−5−メチルハイド
ロキノンのホウ酸エステルにプレニルアルコールもしく
はその誘導体を反応させる方法(特開昭51−6313
9号、同52−42838号)等多くの方法が提案され
ている。これらの方法によつて、たしかに反応収率は改
善されるけれども、他の重要な問題である全トランス体
を得るための立体選択性の向上は何ら改善されない。
In order to improve this drawback, 2,3-
Dimethoxy-5-methylhydroquinone dimethoxymethyl ether-6-magnesium halide is reacted with a π-allylic nickel complex of polyprenyl halide, or palladium chloride or dichlorbis-(triphenylphosphine)- is used as a catalyst. Method of reacting polyprenyl chloride in the presence of nickel (JP-A-51-11723, JP-A-51-11724)
No.), a method of reacting a π-allylic nickel complex of polyprenyl halide using 2,3-dimethoxy-5-methyl-6-halogenohydroquinone diacetate as a nucleation substance (JP-A No. 48-85546, same) 50-5
8021), a method of reacting boric acid ester of 2,3-dimethoxy-5-methylhydroquinone with prenyl alcohol or its derivatives (JP-A-51-6313)
Many methods have been proposed, such as (No. 9, No. 52-42838). Although these methods do improve the reaction yield, they do not improve the stereoselectivity for obtaining all-trans isomers, which is another important issue.

たとえば天然の葉タバコ等から抽出されるソラネソール
(C45のオールトランスポリプレニルアルコール)を
C5Oに伸長したのち母核と縮合する場合は、通常シス
/トランス−3/7〜2/8程度の立体異性体混合物が
得られるが、該混合物からトランス体を回収するための
精製操作が極めて煩雑である点および分離されたシス体
中の構成成分(側鎖および母核)が損失となる点におい
て解決すべき課題が存在する。本発明は上記問題を解決
したもので、本発明により下記一般式(1)〔式()中
R1は低級アルキル基もしくはメトキシメチル基を表わ
し、R2とR3はそれぞれメチル基もしくはメトキシ基
を表わすか、またはそれらが結合している炭素原子とと
もにベンゼン環を構成する員子を表わし、R4は置換さ
れていてもよい芳香族炭化水素基を表わし、nは1〜1
1の整数を表わす〕で示される化合物の製造方法が提供
され、該化合物は補酵素Q類、ビタミンK類、ポリプレ
ニルトリメチルキノン類を高収率かつ高立体選択性にて
製造することを可能にする新規な中間体である。
For example, when solanesol (C45 all-trans polyprenyl alcohol) extracted from natural leaf tobacco etc. is elongated to C5O and then condensed with the mother nucleus, the stereoisomerism is usually about cis/trans-3/7 to 2/8. However, the problem is that the purification operation to recover the trans isomer from the mixture is extremely complicated, and the constituent components (side chains and core) of the separated cis isomer are lost. There are issues that need to be addressed. The present invention has solved the above-mentioned problems, and the present invention provides the following general formula (1) [wherein R1 represents a lower alkyl group or a methoxymethyl group, and R2 and R3 each represent a methyl group or a methoxy group , or a member constituting a benzene ring together with the carbon atom to which they are bonded, R4 represents an optionally substituted aromatic hydrocarbon group, and n is 1 to 1.
represents an integer of 1] is provided, and the compound is capable of producing coenzymes Q, vitamin K, and polyprenyltrimethylquinones in high yield and with high stereoselectivity. It is a novel intermediate for

本発明はプレニルアルコール誘導体例えばソラネソール
に鎖伸長反応を適用したのち母核と縮合するよりも、母
核にC5のプレニル基をトランス配置で導入した中間体
を製造し、次いで最終生成物におけるイソプレン骨格の
炭素数よりもC5少ないポリプレニル鎖を、先に導入し
たプレニル基に結合するのが立体選択性に関して有利で
あるという思想並びに知見に立脚している。
Rather than applying a chain elongation reaction to a prenyl alcohol derivative, such as solanesol, and then condensing it with the mother nucleus, the present invention produces an intermediate in which a C5 prenyl group is introduced into the mother nucleus in a trans configuration, and then the isoprene skeleton in the final product. This is based on the idea and knowledge that it is advantageous in terms of stereoselectivity to bond a polyprenyl chain having fewer C5 carbon atoms than the prenyl group introduced previously.

(1)で示される化合物は、かかる思想に適合する中間
体であり、かつその製造が容易かつ安価であるという工
業的意義の大きい化合物である。式(1)の化合物は本
発明によれば、下記一般式()〔式()中R1、R2お
よびR3は式(1)におけると同じ意味であり、Yは・
・ロゲン原子を表わす]で示される化合物と下記式(V
)式(V)中R4は式(I)におけると同じ意味であり
、Xはハロゲン原子もしくはトシル基を表わす〕で示さ
れる化合物とを銅化合物触媒の存在下に反応させること
により下記一般式()〔式()中R1、R2、R3およ
びR4は前記定義である〕で示される化合物を製造し、
これと下記一般式()〔式()中nは式(I)における
と同じ意味であり、Xはハロゲン原子もしくはトシル基
を表わす〕で示されるプレニル誘導体とを塩基性化合物
の存在下に縮合反応させることにより製造される。
The compound represented by (1) is an intermediate that conforms to this idea, and is a compound of great industrial significance because it is easy and inexpensive to produce. According to the present invention, the compound of formula (1) has the following general formula () [in formula (), R1, R2 and R3 have the same meanings as in formula (1), and Y is
・represents a rogene atom] and the following formula (V
) In formula (V), R4 has the same meaning as in formula (I), and X represents a halogen atom or a tosyl group] in the presence of a copper compound catalyst to form the following general formula ( ) [In formula (), R1, R2, R3 and R4 are as defined above] is produced,
This is condensed with a prenyl derivative represented by the following general formula () [in formula (), n has the same meaning as in formula (I), and X represents a halogen atom or a tosyl group] in the presence of a basic compound. Manufactured by reaction.

さらに式(V)で示される化合物はハロゲン化第一銅触
媒の存在下対応するスルホニル・・ラード(R4SO2
X)とイソプレンとを反応させることによつて製造する
ことができる〔J.Org.Chem.35、4217
(1970)〕o〔上記式中R4およびXは前記定義で
ある〕上記反応により式(V)の化合物を製造すること
、kらびに該化合物を本発明で使用することの利点は出
発物質として用いるイソプレンとスルホニルハライドが
安価であり、両者の反応収率が高く、かつ生成物である
トランス体をシス体から分離するのが極めて容易である
点に存する。
Furthermore, the compound represented by formula (V) can be prepared by using the corresponding sulfonyl rad (R4SO2) in the presence of a cuprous halide catalyst.
X) and isoprene [J. Org. Chem. 35, 4217
(1970)] [in the above formula, R4 and The isoprene and sulfonyl halide used are inexpensive, the reaction yield of both is high, and it is extremely easy to separate the trans isomer from the cis isomer.

したがつて分離されたシス体を廃棄しても、なおかつ経
済的である。上記トランス体とシス体とは一般に融点の
差を利用して固(トランス体)一液(シス体)分離する
ことができる。本発明において母核形成物質として用い
る式()のグリニャール試薬は、対応するハロゲン化物
にマグネシウムを、自体公知の条件下(たとえばジエチ
ルエーテル、テトラヒドロフラン等の溶媒中温度0〜6
0℃)で反応させて得られる。
Therefore, it is still economical to discard the separated cis isomer. Generally, the trans isomer and the cis isomer can be separated into solid (trans isomer) and liquid (cis isomer) by utilizing the difference in melting point. The Grignard reagent of formula () used as a nucleation substance in the present invention is prepared by adding magnesium to the corresponding halide under conditions known per se (for example, in a solvent such as diethyl ether or tetrahydrofuran at a temperature of 0 to 6
0°C).

こうして調製された式()のグリニャール試薬と式(v
)の化合物との反応は銅化合物たとえばハロゲン化第一
銅( CuY.Yは・・ロゲン原子)、塩化銅リチウム
(LiCuCl2、Li2CuCl4)等の存在下で行
なわれる。反応方法はグリニャール試薬を銅化合物と反
応させて下記式(りで示される化合物に誘導したのち式
(V)の化合物と反応させる方法でもよく、また式(V
)の化合物と銅化合物触媒の混合溶液中に該グリニャー
ル試薬を添加する方法でもよい。前記のグリニャール試
薬()生成反応および引続く化合物(V)とグリニヤー
ル試薬()および/またはその銅誘導体(’)(以下グ
リニヤール試薬類ということがある)との反応は、窒素
、アルゴン、ヘリウム等の不活性ガス雰囲気下で行なう
のが好ましい。
The thus prepared Grignard reagent of formula () and the formula (v
) is carried out in the presence of a copper compound such as cuprous halide (CuY.Y is a halogen atom), lithium copper chloride (LiCuCl2, Li2CuCl4), etc. The reaction method may be a method of reacting a Grignard reagent with a copper compound to derive a compound represented by the following formula (R), and then reacting it with a compound of formula (V).
) The Grignard reagent may be added to a mixed solution of the compound and the copper compound catalyst. The aforementioned Grignard reagent () production reaction and the subsequent reaction between compound (V) and Grignard reagent () and/or its copper derivative (') (hereinafter sometimes referred to as Grignard reagents) are carried out using nitrogen, argon, helium, etc. It is preferable to carry out the reaction under an inert gas atmosphere.

グリニャール試薬類と化合物(V)との反応で用いるこ
とのできる溶媒はジエチルエーテル、テトラヒドロフラ
ン、ジオキサン、ジエチレングリコールジメチルエーテ
ル等のエーテル類、ベンゼン、トルエン、キシレン等の
芳香族炭化水素、ヘキサン、ヘプタン、オクタン等の脂
肪族炭化水素類、へキサメチルホスホリツクトリアミド
等の単独もしくは混合物である。これらの溶媒はグリニ
ャール試薬生成反応の溶媒と同一である必要はない。反
応は温度約−70℃〜約60℃の範囲で行なうことがで
きるが、操作上の簡便さ、反応の選択性等を考慮すると
、−20℃〜室温で行なうのが好ましい。反応時間は温
度によつても異なるが1〜20時間である。本発明で使
用する化合物(V)は2官能性であり、−SO2R4基
に対しα一位炭素に結合している水素原子も活性化され
ているので、反応初期においては次に示すような二つの
反応が競争的に進行する。
Solvents that can be used in the reaction between Grignard reagents and compound (V) include ethers such as diethyl ether, tetrahydrofuran, dioxane, and diethylene glycol dimethyl ether, aromatic hydrocarbons such as benzene, toluene, and xylene, hexane, heptane, and octane. aliphatic hydrocarbons, hexamethylphosphoric triamide, etc. alone or in mixtures. These solvents do not need to be the same as the solvent for the Grignard reagent production reaction. The reaction can be carried out at a temperature in the range of about -70°C to about 60°C, but in consideration of operational simplicity, reaction selectivity, etc., it is preferably carried out at -20°C to room temperature. The reaction time varies depending on the temperature, but is 1 to 20 hours. The compound (V) used in the present invention is difunctional, and the hydrogen atom bonded to the α-1 carbon with respect to the -SO2R4 group is also activated, so at the initial stage of the reaction, the following difunctional Two reactions proceed competitively.

このことは、反応方式としてグリニャール試薬類の中へ
化合物(v)を添加するよりも、化合物(V)の中ヘグ
リニヤール試薬類を加えていくのが好ましいことを示唆
する。
This suggests that it is preferable to add Grignard reagents into compound (V) rather than adding compound (v) into Grignard reagents as a reaction method.

したがつて具体的には(a)化合物(V)と銅化合物触
媒の混合物溶液中にグリニャール試薬()を加えるか、
または(b)化合物(V)の溶液中にグリニャール試薬
の銅誘導体(’)を加える方法を採用するのが適当であ
る。
Therefore, specifically, (a) a Grignard reagent () is added to a mixture solution of compound (V) and a copper compound catalyst;
Alternatively, it is appropriate to adopt a method (b) of adding the copper derivative (') of the Grignard reagent to the solution of compound (V).

上言口a)、(b)のいずれの方法でも反応の進行に伴
なつて銅触媒が再生されてくるので、反応速度を考慮し
ていずれかを選べばよい。グリニャール試薬類は化合物
(V)に対して当モル量ないし4倍モル量の範囲内で使
用するのが好ましい。触媒としてハロゲン化第一銅を用
いる場合のハロゲンは、塩素、臭素もしくはヨウ素が適
当である。銅化合物触媒の使用量は上述の如き反応方式
に応じて適宜決定されるべきであるが、通常は化合物(
V)に対して1モル%ないし2倍モル量の範囲内である
。本発明で用いる式()のグリニャール試薬において、
R1が低級アルキル基である場合の例はメチル、エチル
、プロピル、ブチル、ペンチルであるが、該基は最終的
には脱離されるものであるから、経済性の点でメチル基
が最も適当である。
In both methods a) and (b) above, the copper catalyst is regenerated as the reaction progresses, so either method may be selected in consideration of the reaction rate. Grignard reagents are preferably used in an equimolar amount to 4 times the molar amount of compound (V). When cuprous halide is used as a catalyst, chlorine, bromine or iodine is suitably used as the halogen. The amount of the copper compound catalyst to be used should be determined appropriately depending on the reaction method as described above, but usually the amount of the copper compound catalyst (
The amount is within the range of 1 mol % to 2 times the amount of V). In the Grignard reagent of formula () used in the present invention,
Examples of lower alkyl groups in which R1 is methyl, ethyl, propyl, butyl, and pentyl; however, since the group is ultimately eliminated, methyl is the most suitable group from the economic point of view. be.

式(V)の化合物においてR4で表わされる置換基を有
していてもよい芳香族炭化水素基とは、例えばフエニル
、トリル、キシリル、ナフチル等のグリニャール試薬と
反応しないものである。本発明において、上述のように
して得られた式()の化合物と式()のプレニル誘導体
との縮合反応は、塩基性化合物の存在下すなわち塩基性
条件下で行なわれる。式()の化合牧はプレニル誘導体
との反応収率が高く、この点にも本発明において式()
の化合物を用いる利点が存する。塩基性化合物の特に好
ましい例はn−ブチルリチウム、メチルリチウム、フエ
ニルリチウム等の有機リチウム化合物であるが、エチル
マグネシウムブロマイド、フエニルマグネシウムプロマ
イド等のグリニャール試薬、ジイソプロピルリチウムア
ミド、リチウムアミド、ナトリウムアミド等のアミド類
、カリウム一t−ブトキシド等を使用することもできる
。縮合反応は窒素、ヘリウム、アルゴン等の不活性ガス
雰囲気下、無水の有機溶媒中式()の化合物に塩基性化
合物を作用させて式()の化合物のアニオンを生成させ
、これに式()のプレニル誘導体を徐々に加えることに
より行なうのが好ましい。塩基性化合物の使用量は化学
量論量の1〜2倍程度が適当である。式()の化合物に
対する式()の化合物の量には特別の制限はないが、約
等モル量の使用が一般的である。反応は−78℃のよう
な低温から室温の範囲にわたつて可能であるが、式()
のプレニル誘導体の添加時の温度はO℃以下が好ましい
。式()と式()の化合物の混合後温度を徐々に室温ま
で上昇させることにより、反応をほとんど完全に終結さ
せることができる。反応後の反応混合物に酢酸、塩酸、
リン酸等の酸を少量添加して中和し、次いでクロロホル
ム、イソプロピルエーテル、ジエチルエーテル、石油エ
ーテル、n−ヘキサン等の溶媒で抽出、水洗、乾燥する
ことにより生成した式(1)の化合物を回収することが
できる。補酵素Q類、ビタミンK類、ポリプレニルトリ
メチルキノン類を製造するうえで収率ならびに立体選択
性に関して有利性を発揮し本発明方法により製造するこ
とができる新規な化合物(1)の例を以下に挙げる。
The optionally substituted aromatic hydrocarbon group represented by R4 in the compound of formula (V) is one that does not react with Grignard reagents, such as phenyl, tolyl, xylyl, naphthyl, and the like. In the present invention, the condensation reaction between the compound of formula () obtained as described above and the prenyl derivative of formula () is carried out in the presence of a basic compound, that is, under basic conditions. The compound of the formula () has a high reaction yield with the prenyl derivative, and in this respect, the compound of the formula () is also used in the present invention.
There are advantages to using compounds such as Particularly preferred examples of basic compounds are organic lithium compounds such as n-butyllithium, methyllithium, phenyllithium, etc., Grignard reagents such as ethylmagnesium bromide, phenylmagnesium bromide, diisopropyllithium amide, lithium amide, sodium amide. Amides such as, potassium t-butoxide, etc. can also be used. The condensation reaction involves reacting a basic compound with a compound of formula () in an anhydrous organic solvent under an inert gas atmosphere such as nitrogen, helium, or argon to produce an anion of the compound of formula (). Preferably this is carried out by gradual addition of the prenyl derivative. The appropriate amount of the basic compound to be used is about 1 to 2 times the stoichiometric amount. There is no particular limit to the amount of the compound of formula () relative to the compound of formula (), but approximately equimolar amounts are generally used. Although the reaction is possible over a range of temperatures from as low as -78°C to room temperature, the formula ()
The temperature at the time of addition of the prenyl derivative is preferably 0° C. or lower. By gradually increasing the temperature to room temperature after mixing the compounds of formula () and formula (), the reaction can be almost completely terminated. After the reaction, acetic acid, hydrochloric acid,
The compound of formula (1) produced by adding a small amount of acid such as phosphoric acid to neutralize it, then extracting with a solvent such as chloroform, isopropyl ether, diethyl ether, petroleum ether, n-hexane, washing with water, and drying. It can be recovered. Examples of novel compounds (1) that exhibit advantages in terms of yield and stereoselectivity in producing coenzymes Q, vitamin K, and polyprenyltrimethylquinones and can be produced by the method of the present invention are shown below. Listed below.

上記式においてR4はすでに定義したようにフエニル、
トリル、キシリル、ナフチル等の置換もしくは非置換の
芳香族炭化水素基を表わし、nは1〜11の整数を表わ
す。
In the above formula, R4 is phenyl as defined above,
It represents a substituted or unsubstituted aromatic hydrocarbon group such as tolyl, xylyl, naphthyl, etc., and n represents an integer of 1 to 11.

これらの化合物は次式で示す工程により医薬品として有
用な前記のキノン類に誘導される。次に実施例により本
発明をさらに説明する。
These compounds are derived into the above-mentioned quinones useful as pharmaceuticals through the steps shown by the following formula. Next, the present invention will be further explained by examples.

参考例 1ブロムトリメチルヒドロキノンジメチルエー
テルの調製L.I.Smithらの方法〔J.Am.C
hem.SOc.、64.440(1942)〕に従が
い、まずトリメチルキノン4207を四塩化炭素41に
溶解し、臭素4487を室温下に滴下(3時間)し、滴
下後1時間攪拌した。
Reference Example 1 Preparation of bromotrimethylhydroquinone dimethyl etherL. I. The method of Smith et al. [J. Am. C
hem. SOc. , 64.440 (1942)], trimethylquinone 4207 was first dissolved in carbon tetrachloride 41, bromine 4487 was added dropwise at room temperature (3 hours), and the mixture was stirred for 1 hour after the dropwise addition.

反応混合物を飽和炭酸水素ナトリウム水溶液で処理した
後水洗し、析出した結晶を口別し、乾燥した。母液を減
圧下に濃縮して得られた黒色結晶を熱エタノールに溶解
し、固体状炭酸水素ナトリウムを炭酸ガスの発生が止む
まで加えた。硝酸を少量づつ加えて、液が赤色から黄色
に変化した時点で冷却して結晶をとり出し、母液はさら
に濃縮して結晶をとり出した。得られた結晶を熱エタノ
ールから再結晶することにより4757(収率75%)
のブロムキノンを得た。このものを酢酸31/水21中
に懸濁し、亜鉛280yを加えて80〜90℃にて2時
間、次いで還流下に2時間反応した。未反応の亜鉛をデ
カンテーシヨンにより分離したのち水中に反応液をあけ
、白色結晶のトリメチルブロムハイドロキノン3837
を得た(収率80%)。上記ブロムハイドロキノン18
8yをジメチル硫酸1060m1中に懸濁し、窒素雰囲
気下に水酸化カリウム(1700m9)/水(3400
m0溶液を約10℃で少量づつ加えた。
The reaction mixture was treated with a saturated aqueous sodium hydrogen carbonate solution, washed with water, and the precipitated crystals were separated and dried. The black crystals obtained by concentrating the mother liquor under reduced pressure were dissolved in hot ethanol, and solid sodium hydrogen carbonate was added until the evolution of carbon dioxide gas stopped. Nitric acid was added little by little, and when the liquid changed from red to yellow, it was cooled and the crystals were taken out.The mother liquor was further concentrated and the crystals were taken out. 4757 (yield 75%) was obtained by recrystallizing the obtained crystals from hot ethanol.
of bromoquinone was obtained. This material was suspended in 31 parts of acetic acid/2 parts of water, and 280y of zinc was added thereto and reacted at 80 to 90°C for 2 hours and then under reflux for 2 hours. After separating unreacted zinc by decantation, the reaction solution was poured into water, and white crystals of trimethylbromohydroquinone 3837 were extracted.
was obtained (yield 80%). The above bromohydroquinone 18
8y was suspended in 1060 ml of dimethyl sulfate and mixed with potassium hydroxide (1700 m9)/water (3400 ml) under nitrogen atmosphere.
The m0 solution was added in small portions at approximately 10°C.

滴下後反応温度を50〜60℃に上げて1時間攪拌し、
水にあけてエーテルで抽出し、エーテル層を5%水酸化
ナトリウム水溶液にて洗浄したのち水洗、乾燥し、濃縮
した。析出した結晶をメタノールにより再結晶してブロ
ムトリメチルヒドロキノンジメチルエーテル1307(
収率62%)を得た。参考例 2 ブロムメチルナフトハイドロキノンジメチルエーテルの
調製R.Adamsらの方法〔J.Am.Chem.S
Oc.、り、528(1941)〕に従つた。
After dropping, the reaction temperature was raised to 50-60°C and stirred for 1 hour.
The mixture was poured into water and extracted with ether, and the ether layer was washed with a 5% aqueous sodium hydroxide solution, washed with water, dried, and concentrated. The precipitated crystals were recrystallized from methanol to give bromotrimethylhydroquinone dimethyl ether 1307 (
A yield of 62% was obtained. Reference Example 2 Preparation of bromomethylnaphthohydroquinone dimethyl etherR. The method of Adams et al. [J. Am. Chem. S
Oc. , 528 (1941)].

2−メチルナフトキノン2007、乾燥酢酸ナトリウム
400y1酢酸1800m1を50℃に加熱し、臭素2
047を滴下し、同温度で18時間攪拌した。
2-Methylnaphthoquinone 2007, dry sodium acetate 400y1 acetic acid 1800ml were heated to 50°C, and bromine 2
047 was added dropwise, and the mixture was stirred at the same temperature for 18 hours.

反応液を41の水にあけ、冷却してから析出する結晶を
口別し、メタノールで再結晶することにより黄色のブロ
ムキノン225yを得た。上記ブロムキノン130yを
95%エタノール1750m1に加え、塩化第1錫36
07の濃塩酸360m1溶液を氷冷下に添加して、同温
度で4時間撹拌した。なお反応は窒素ガス雰囲気下で行
つた。反応混合物に水1700m1を加え、析出した結
晶を、加熱により再溶解したのち放冷して白色結晶11
47(収率87%)を取り出した。該ブロムハイドロキ
ノン1037をジメチル硫酸530m1に懸濁し、氷冷
しつつ窒素ガス雰囲気下に水酸化カリウム(8467)
/水(1700m0を少量づつ加えた。滴下後反応温度
を50〜60℃に上げて1時間攪拌した。反応混合物を
水にあけてエーテルで抽出し、エーテル層を5%水酸化
ナトリウム水溶液次いで水で洗浄し、乾燥後、濃縮して
得られた結晶をメタノールで再結晶してブロムメチルナ
フトハイドロキノンジメチルエーテル797(収率69
.3%)を得た。実施例 1 参考例1の方法で調製したブロムトリメチルヒドロキノ
ンジメチルエーテル12.96f(50mm01)をテ
トラヒドロフラン(THF)中少量のエチルブロマイド
の存在下マグネシウム1.447と室温で反応させて、
該ヒドロキノン誘導体のグリニャール試薬を得た。
The reaction solution was poured into 41ml of water, cooled, and the precipitated crystals were separated and recrystallized with methanol to obtain yellow bromoquinone 225y. Add 130y of the above bromoquinone to 1750ml of 95% ethanol, and add 36ml of stannous chloride.
A solution of 07 in 360 ml of concentrated hydrochloric acid was added under ice cooling, and the mixture was stirred at the same temperature for 4 hours. Note that the reaction was conducted under a nitrogen gas atmosphere. 1,700 ml of water was added to the reaction mixture, and the precipitated crystals were redissolved by heating and then allowed to cool to form white crystals.
47 (yield 87%) was taken out. The bromohydroquinone 1037 was suspended in 530 ml of dimethyl sulfate, and potassium hydroxide (8467) was added under a nitrogen gas atmosphere while cooling on ice.
/water (1700m0) was added little by little. After the dropwise addition, the reaction temperature was raised to 50-60°C and stirred for 1 hour. The reaction mixture was poured into water and extracted with ether, and the ether layer was mixed with a 5% aqueous sodium hydroxide solution and then water. After washing with
.. 3%). Example 1 12.96 f (50 mm 01) of bromotrimethylhydroquinone dimethyl ether prepared by the method of Reference Example 1 was reacted with 1.447 g of magnesium in the presence of a small amount of ethyl bromide in tetrahydrofuran (THF) at room temperature.
A Grignard reagent of the hydroquinone derivative was obtained.

1−(ベンゼンスルホニル)−2−メチル−4クロロ−
2−ブテン(トランス体)6.17(25mm01)お
よび臭化第一銅4.17をTHF5Oml中に懸濁させ
ておき、−10〜0℃にて前記グリニャール試薬(TH
Fl5Oml中溶液)を約2時間にわたつて滴下した。
1-(benzenesulfonyl)-2-methyl-4chloro-
6.17 (25 mm01) of 2-butene (trans isomer) and 4.17 cuprous bromide were suspended in 50 ml of THF, and the Grignard reagent (TH
A solution of F1 in 50 ml) was added dropwise over about 2 hours.

滴下後さらに2時間攪拌して反応を終了した。反応液を
水にあけて酢酸37/水20m1にて中和し、クロロホ
ルムで抽出し、水洗、乾燥後のクロロホルム層から溶媒
を蒸発した。残分にメタノール200TILIを加えて
析出した結晶を回収し、母液を濃縮してさらに結晶をと
り出した。こうして得られた融点127〜129℃白色
結晶の2・3・5−トリメチル−5一(3′−メチル−
4′−ベンゼンスルホニル−2′一ブテン一1/−イル
)−ヒドロキノンジメチルエーテルの収量は6.67f
(収率68.5%)であつた。構造は下記により確認し
た。次いで上記化合物3.17(8.4mm01)をT
HF(48m0−ヘキサメチルホスホリツクトリアミド
(HMPA)(16m1)の混合溶媒に溶解し、この溶
液に−60℃にてn−ブチルリチウムの15%n−ヘキ
サン溶液6.7m1を滴下し、さらに15分後にオール
トランス型ゲラニルゲラニルプロマイド2,96f7(
8.4Ttm01)のTHF4Oml中溶液を滴下した
After the dropwise addition, the mixture was further stirred for 2 hours to complete the reaction. The reaction solution was poured into water, neutralized with 37 acetic acid/20 ml of water, extracted with chloroform, washed with water, dried, and the solvent was evaporated from the chloroform layer. 200 TILI of methanol was added to the residue to collect the precipitated crystals, and the mother liquor was concentrated to collect further crystals. The thus obtained white crystals of 2,3,5-trimethyl-5-(3'-methyl-
The yield of 4'-benzenesulfonyl-2'-butene-1/-yl)-hydroquinone dimethyl ether was 6.67 f.
(yield 68.5%). The structure was confirmed as follows. Then, the above compound 3.17 (8.4 mm01) was added to T
HF (48m) was dissolved in a mixed solvent of 0-hexamethylphosphoric triamide (HMPA) (16ml), and 6.7ml of a 15% n-hexane solution of n-butyllithium was added dropwise to this solution at -60°C. After 15 minutes, all-trans geranylgeranyl bromide 2,96f7 (
A solution of 8.4Ttm01) in THF4Oml was added dropwise.

同温度で1時間攪拌したのち反応温度を徐々に室温に上
げ、室温にて2時間反応を継続して終了した。反応混合
物を水にあけて酢酸で酸性にしたのち、イソプロピルエ
ーテルで抽出し、イソプロピルエーテル層を水洗し、乾
燥した。イソプロピルエーテル溶液から減圧下に溶媒を
留去し、析出した未反応の2・3・5トリメチル−5−
(3′−メチル−4′−ベンゼンスルホニル−2′−ブ
テン−1′−イル)−ヒドロキノンジメチルエーテルを
▲別してイソプロピルエーテル/ヘキサン=3/7混合
液で洗浄した。母液と洗液を合せて濃縮したのちシリカ
ゲルカラムクロマトグラフイ一(イソプロピルエーテル
/ヘキサン−3/7)にて精製し、目的とする縮合生成
物4.167(収率75%)を得た。構造確認は次のと
おり。〔CH3O−ピークとの重なりにより不明である
が(−CH2→ま3.10−3,25付近にある)、し
NOυ2積算値からこの位置に プロトンも
含まれていることが確認された]ノ 実施例 2 参考例2の方法で調製したブロムメチルナフトハイドロ
キノンジメチルエーテルを実施例1と同様にしてTHF
中少量のエチルブロマイドの存在下にマグネシウムと反
応させて、対応するグリニャール試薬を調製した。
After stirring at the same temperature for 1 hour, the reaction temperature was gradually raised to room temperature, and the reaction was continued at room temperature for 2 hours to complete. The reaction mixture was poured into water and made acidic with acetic acid, extracted with isopropyl ether, and the isopropyl ether layer was washed with water and dried. The solvent was distilled off from the isopropyl ether solution under reduced pressure, and the precipitated unreacted 2.3.5-trimethyl-5-
(3'-Methyl-4'-benzenesulfonyl-2'-buten-1'-yl)-hydroquinone dimethyl ether was separated out and washed with a 3/7 mixture of isopropyl ether/hexane. The mother liquor and washing solution were combined and concentrated, and then purified by silica gel column chromatography (isopropyl ether/hexane-3/7) to obtain the desired condensation product 4.167 (yield 75%). The structure confirmation is as follows. [Although it is unclear due to the overlap with the CH3O- peak (-CH2 → is around 3.10-3,25), it was confirmed from the NOυ2 integrated value that protons are also included at this position] Example 2 Bromomethylnaphthohydroquinone dimethyl ether prepared by the method of Reference Example 2 was dissolved in THF in the same manner as in Example 1.
The corresponding Grignard reagent was prepared by reaction with magnesium in the presence of a moderate amount of ethyl bromide.

1−(ベンゼンスルホニル)−2−メチル−4ークロロ
−2−ブテン(トランス体)1.77(7mm01)を
10m1のTHFに溶解した溶液中に当モル量の臭化第
一銅を懸濁させておき、0℃にて上記グリニャール試薬
(16mm0/40m1THFの溶液)を1時間にわた
つて滴下した。
An equimolar amount of cuprous bromide was suspended in a solution of 1.77 (7 mm01) of 1-(benzenesulfonyl)-2-methyl-4-chloro-2-butene (trans form) dissolved in 10 ml of THF. Then, the Grignard reagent (16 mm 0/40 ml THF solution) was added dropwise at 0° C. over 1 hour.

次いで反応温度を室温に上げて3時間攪拌した。反応液
を氷水中にあけて酢酸酸性としたのちクロロホルムで抽
出し、クロロホルム層を水洗、乾燥後濃縮した。残分に
メタノ一ルを加えて析出した結晶を回収し、母液を濃縮
したのち同様の操作で追加量の結晶を回収した。こうし
て得られた融点156〜157℃、白色結晶状の目的生
成物の収率は70.4%であつた。構造は下記により確
認した。次いで上記化合物2.O5y(5mmo1)を
THF/HMPA−3/1混合溶媒40mlに溶解し、
実施例1と同様にしてこの溶液にn−ブチルリチウムの
15%n−ヘキサン溶液4.34ml1続いてオールト
ランスゲラニルブロマイド1.957(5.5mmo1
)のTHF溶液をそれぞれ滴下し、反応を行なつた。
Then, the reaction temperature was raised to room temperature and stirred for 3 hours. The reaction solution was poured into ice water, acidified with acetic acid, extracted with chloroform, and the chloroform layer was washed with water, dried, and concentrated. Methanol was added to the residue to collect the precipitated crystals, and after concentrating the mother liquor, an additional amount of crystals was collected in the same manner. The yield of the desired product in the form of white crystals with a melting point of 156-157°C was 70.4%. The structure was confirmed as follows. Next, the above compound 2. Dissolve O5y (5 mmol) in 40 ml of THF/HMPA-3/1 mixed solvent,
In the same manner as in Example 1, 4.34 ml of a 15% n-hexane solution of n-butyllithium was added to this solution, followed by 1.957 ml of all-transgeranyl bromide (5.5 mmol).
) was added dropwise to react.

反応液を水にあけて酢酸で中和したのちイソプロピルエ
ーテルで抽出した。イソプロピルエーテル層から回収し
た粗生成物の収量は3.70yであり、このものをシリ
カゲルカラムクロマトグラフイー(イソプロピルエーテ
ル/nーヘキサン−3/7)にて精製し、目的とする縮
合反応生成物2.517(収率73%を得た)。構造は
下記により確認した。実施例 3 実施例2において1−(ベンゼンスルホニル)−2−メ
チル−4−クロロ−2−ブテン(7mmol)の代りに
1−(ベンゼンスルホニル)2−メチル−4−トシル−
2−ブテン(7mmo1)を用い、グリニャール試薬滴
下後室温で6時間反応を行なつた以外は実施例2と同様
にして、2メチル−3−(3/−メチル−4′−ベンゼ
ンスルホニル−2′−ブテン−1′−イル)ナフトハイ
ドロキノンを調製し(収率35.2%)、次いでこのも
のを用いて、実施例2と同様にして縮合反応生成物を得
た。
The reaction solution was poured into water, neutralized with acetic acid, and then extracted with isopropyl ether. The yield of the crude product recovered from the isopropyl ether layer was 3.70y, and this product was purified by silica gel column chromatography (isopropyl ether/n-hexane-3/7) to obtain the desired condensation reaction product 2. .517 (73% yield was obtained). The structure was confirmed as follows. Example 3 In Example 2, 1-(benzenesulfonyl)2-methyl-4-tosyl- was used instead of 1-(benzenesulfonyl)-2-methyl-4-chloro-2-butene (7 mmol).
2-methyl-3-(3/-methyl-4'-benzenesulfonyl-2) was prepared in the same manner as in Example 2, except that 2-butene (7 mmol) was used and the reaction was carried out at room temperature for 6 hours after dropping the Grignard reagent. '-Buten-1'-yl) naphthohydroquinone was prepared (yield 35.2%), and then using this product, a condensation reaction product was obtained in the same manner as in Example 2.

実施例 4 ブロムメチルナフトハイドロキノンジメトキシメチルエ
ーテル20.64f7(60mmol)とマグネシウム
1.737とを少量の臭化エチルの存在下THF中室温
で反応させて、該ヒドロキノン誘導体のグリニャール試
薬を得た。
Example 4 20.64f7 (60 mmol) of bromomethylnaphthohydroquinone dimethoxymethyl ether and 1.737 g of magnesium were reacted in THF at room temperature in the presence of a small amount of ethyl bromide to obtain a Grignard reagent of the hydroquinone derivative.

1−(ベンゼンスルホニル)−2−メチル−4−クロロ
−2−ブテン(トランス体)7.32f7(30mmo
l)と臭化第一銅4.937とをTHF100ml中に
懸濁させておき、上記グリニャール試薬(THF200
ml中溶液)をO℃にて3時間にわたつて滴下した。
1-(benzenesulfonyl)-2-methyl-4-chloro-2-butene (trans form) 7.32f7 (30mmo
1) and 4.937 cuprous bromide were suspended in 100 ml of THF, and the above Grignard reagent (THF 200 ml) was suspended in 100 ml of THF.
ml solution) was added dropwise over 3 hours at 0°C.

滴下後同温度でさらに2時間反応させた。反応混合物を
水にあけて酢酸4.07の水40ml中溶液にて中和し
たのち、クロロホルムで抽出した。水洗、乾燥後のクロ
ロホルム層を蒸発させ、残分にメタノール200m1を
加えて0℃で結晶を析出させた。こうして得られた融点
73−75℃、白色結晶状の目的生成物の収量は10,
2y(収率72%)であつた。構造は下記により確認し
た。上記化合物7.17(15mm01)をTHF(9
0m0/HMPA(30m0の混合溶媒中に溶解し、実
施例1と同様の操作で該溶液にn−ブチルリチウムの1
5%n−ヘキサン溶液22.5m11次いでオールトラ
ンスゲラニルゲラニルフロマイド5,31y(15mm
01)のTHF2Oml中溶液をそれぞれ滴下して反応
を行なつた。
After the dropwise addition, the reaction was continued for another 2 hours at the same temperature. The reaction mixture was poured into water, neutralized with a solution of 4.07 acetic acid in 40 ml of water, and then extracted with chloroform. After washing with water and drying, the chloroform layer was evaporated, and 200 ml of methanol was added to the residue to precipitate crystals at 0°C. The yield of the desired product in the form of white crystals with a melting point of 73-75°C was 10,
2y (yield 72%). The structure was confirmed as follows. The above compound 7.17 (15 mm01) was dissolved in THF (9
0m0/HMPA (dissolved in a mixed solvent of 30m0), and added 1% of n-butyllithium to the solution in the same manner as in Example 1.
22.5ml of 5% n-hexane solution, then all-transgeranylgeranylfuromide 5,31y (15mm
The reaction was carried out by dropping a solution of 01) in 20 ml of THF.

反応液を水にあけて酢酸で中和したのちイソプロピルエ
ーテルで抽出した。イソプロピルエーテル層から回収し
た粗生成物13.0yをシリカゲルカラムクロマトグラ
フイ一(イソプロピルエーテル/n−ヘキサン=4/6
)にて精製し、目的の縮合生成物を7.27(収率64
,3%)得た。構造は下記により確認した。実施例 5 2・3・4・5−テトラメトキシ−6−メチルー1−ブ
ロムベンゼン14.5y(50mm01)と金属マグネ
シウム1.6f7(66mm01)をテトラヒドロフラ
ン120m1中で反応させてグリニャール試薬を調製し
た。
The reaction solution was poured into water, neutralized with acetic acid, and then extracted with isopropyl ether. 13.0y of the crude product recovered from the isopropyl ether layer was subjected to silica gel column chromatography (isopropyl ether/n-hexane = 4/6
) to obtain the desired condensation product with a yield of 7.27 (yield: 64
, 3%) obtained. The structure was confirmed as follows. Example 5 A Grignard reagent was prepared by reacting 14.5y (50mm01) of 2,3,4,5-tetramethoxy-6-methyl-1-bromobenzene and 1.6f7 (66mm01) of metallic magnesium in 120ml of tetrahydrofuran.

1−(ベンゼンスルホニル)−2−メチル−4一クロル
一2−ブテン(トランス体)6.1y(25mm01)
および臭化第一銅7.17(50mm01)のテトラヒ
ドロフラン100m1中懸濁液に、上記グリニャール試
薬をO℃にて2時間で滴下した。
1-(Benzenesulfonyl)-2-methyl-4-1chloro-2-butene (trans form) 6.1y (25mm01)
The above Grignard reagent was added dropwise to a suspension of 7.17 (50 mm01) of cuprous bromide in 100 ml of tetrahydrofuran at 0° C. over 2 hours.

滴下終了後さらに同温度で2時間撹拌して反応を終了し
た。反応液を氷水中にあけて酢酸にて酸性としたのちク
ロロホルムで抽出し、クロロホルム層を水洗、乾燥した
。該クロロホルム溶液から溶媒を減圧下に留去し、残分
(17.87)をシリカゲルカラムクロマトグラフイ一
(クロロロホルム展開溶媒)による精製に付したところ
、前留分として2・3・4・5−テトラメトキシ6−メ
チルベンゼン8.57が得られ、後留分として目的物8
.77(収率80%)が得られた。このものは液状で得
られるが、長時間の放置により結晶化する(粗製物融点
71〜75℃)。構造確認は以下のとおり。Ca.3.
6O−3.9:CH3O−ピークとの重なりにより不明
ではあるが、−CH2SO2−プロトン2個分が混入し
て℃・ることが積算値から確認された。
After the dropwise addition was completed, the mixture was further stirred at the same temperature for 2 hours to complete the reaction. The reaction solution was poured into ice water, acidified with acetic acid, extracted with chloroform, and the chloroform layer was washed with water and dried. The solvent was distilled off from the chloroform solution under reduced pressure, and the residue (17.87) was purified by silica gel column chromatography (chloroform developing solvent). 8.57% of 5-tetramethoxy6-methylbenzene was obtained, and the desired product 8 was obtained as the after-distillate.
.. 77 (yield 80%) was obtained. Although this product is obtained in liquid form, it crystallizes when left for a long time (crude product melting point: 71-75°C). The structure confirmation is as follows. Ca. 3.
6O-3.9: Although it was unclear due to the overlap with the CH3O- peak, it was confirmed from the integrated value that two -CH2SO2- protons were mixed in at .degree.

上記化合物5y(12mm01)をTHF(72m0/
HMPA(24m1)の混合溶媒に溶解し、実施例1と
同様の操作で該溶液にn−ブチルリチウムの15%n−
ヘキサン溶液11m11次いでオールトランスフアルネ
シルプロマイド2.737(9.6mm01)のTHF
3Oml中溶液をそれぞれ滴下して反応を行なつた。
The above compound 5y (12mm01) was dissolved in THF (72m0/
HMPA (24ml) was dissolved in a mixed solvent, and 15% n-butyllithium was added to the solution in the same manner as in Example 1.
11 ml of hexane solution, then 2.737 (9.6 mm) of all-transfernesyl bromide in THF
The reaction was carried out by dropping each solution in 30ml.

反応液をクロロホルムで抽出し、クロロホルム層から溶
媒を減圧下に留去し、そして残つた残留物6037を高
速液体クロマトグラフイ一(イソプロパノール/n−ヘ
キサン−2/98)にて分取した。それにより未反応ス
ルホンが2.34y回収され(仕込量に対する回収率4
7%)、目的とする縮合生成物が2.52y(仕込フア
ルネシルプロマイドに対し収率42%)得られた。構造
は下記により確認された。〔CH3O−ピークとの重な
りにより明確ではないが、積算値から確認した〕実施例
6 2・3−ジメトキシ−5−メチル−6−ブロムベンゾハ
イドロキノンジメトキシメチルエーテル10.207(
29mm01)と金属マグネシウム0.87(33mm
01)とをテトラヒドロフラン100m1中で反応させ
てグリニヤール試薬を調製した。
The reaction solution was extracted with chloroform, the solvent was distilled off from the chloroform layer under reduced pressure, and the remaining residue 6037 was fractionated using high performance liquid chromatography (isopropanol/n-hexane-2/98). As a result, 2.34y of unreacted sulfone was recovered (recovery rate of 4
7%), and 2.52y of the desired condensation product (yield 42% based on the charged farnesyl bromide) was obtained. The structure was confirmed as follows. [It was not clear due to the overlap with the CH3O- peak, but it was confirmed from the integrated value] Example 6 2,3-dimethoxy-5-methyl-6-bromobenzohydroquinone dimethoxymethyl ether 10.207 (
29mm01) and metal magnesium 0.87(33mm
01) in 100 ml of tetrahydrofuran to prepare a Grignard reagent.

1−(ベンゼンスルホニル)−2−メチル−4一クロル
一2−ブテン(トランス体)4.887(20mm01
)および臭化第一銅4.267(30mm01)のテト
ラヒドロフラン100m1中懸濁液に、上記グリニヤー
ル試薬を0℃にて2時間で滴下した。
1-(benzenesulfonyl)-2-methyl-4-1-chloro-2-butene (trans form) 4.887 (20mm01
) and cuprous bromide 4.267 (30 mm01) in 100 ml of tetrahydrofuran, the above Grignard reagent was added dropwise at 0° C. over 2 hours.

Claims (1)

【特許請求の範囲】 1 下記一般式(IV) ▲数式、化学式、表等があります▼(IV)〔式(IV)中
R^1は低級アルキル基もしくはメトキシメチル基を表
わし、R^2とR^3はそれぞれメチル基もしくはメト
キシ基を表わすかまたはそれらが結合している炭素原子
とともにベンゼン環を構成する員子を表わし、Yはハロ
ゲン原子を表わす〕で示される化合物と下記一般式(V
)▲数式、化学式、表等があります▼(V)〔式(V)
中R^4は置換されていてもよい芳香族▲数式、化学式
、表等があります▼(III)〔式(III)中Xはハロゲン
原子もしくはトシル基を表わし、nは1〜11の整数を
表わす〕で示されるプレニル誘導体とを塩基性化合物の
存在下に縮合反応させることを特徴とする下記一般式(
I )▲数式、化学式、表等があります▼( I )〔式(
I )中R^1、R^2、R^3、R^4およびnは前
記定義である〕で示されるハイドロキノン系化合物の製
造方法。
[Claims] 1 General formula (IV) below ▲ Numerical formulas, chemical formulas, tables, etc. are included ▼ (IV) [In formula (IV), R^1 represents a lower alkyl group or a methoxymethyl group, and R^2 and R^3 each represents a methyl group or a methoxy group, or represents a member constituting a benzene ring together with the carbon atom to which they are bonded, and Y represents a halogen atom] and the following general formula (V
) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (V) [Formula (V)
R^4 is an optionally substituted aromatic ▲ Numerical formula, chemical formula, table, etc. ▼ (III) [In formula (III), X represents a halogen atom or a tosyl group, and n is an integer from 1 to 11. The following general formula (
I ) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ ( I ) [Formula (
I) A method for producing a hydroquinone compound, wherein R^1, R^2, R^3, R^4 and n are as defined above.
JP53102647A 1978-08-22 1978-08-22 Method for producing hydroquinone compounds Expired JPS5938946B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP53102647A JPS5938946B2 (en) 1978-08-22 1978-08-22 Method for producing hydroquinone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53102647A JPS5938946B2 (en) 1978-08-22 1978-08-22 Method for producing hydroquinone compounds

Publications (2)

Publication Number Publication Date
JPS5528960A JPS5528960A (en) 1980-02-29
JPS5938946B2 true JPS5938946B2 (en) 1984-09-20

Family

ID=14333022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53102647A Expired JPS5938946B2 (en) 1978-08-22 1978-08-22 Method for producing hydroquinone compounds

Country Status (1)

Country Link
JP (1) JPS5938946B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100695266B1 (en) 2005-09-27 2007-03-19 (주)파인켐 Method for producing intermediates used for syntheses of coenzyme Q or vitamin K

Also Published As

Publication number Publication date
JPS5528960A (en) 1980-02-29

Similar Documents

Publication Publication Date Title
Closs et al. Carbenes from Alkyl Halides and Organolithium Compounds. V. Formation of Alkylcyclopropenes by Ring Closure of Alkenyl Substituted Carbenoid Intermediates
CN114269717A (en) Catalytic cannabinoid processes and precursors
JPS6145617B2 (en)
EP0065368B1 (en) A process for preparing chromans
JP2567430B2 (en) Carbinol derivative and method for producing the same
Jempty et al. Oxidative coupling reactions using silica-bound ferric chloride
US3862972A (en) Process for preparing Unsaturated Carboxylic Acids
US4270003A (en) Hydroquinone derivatives and preparation thereof
EP0012824B1 (en) Process for the manufacture of alpha-tocopherol and novel intermediate in this process
JPS5938945B2 (en) Method for producing hydroquinone derivatives
Lomas et al. Conformational isomerism in o-tolyldi-tert-butylcarbinol
DK170773B1 (en) Process for the preparation of d-alpha-tocopherol
JPS5938946B2 (en) Method for producing hydroquinone compounds
JPH0639468B2 (en) Hydroquinone derivative
US20240174627A1 (en) Catalytic cannabinol synthesis and precursors
US3879449A (en) 1-Phenyl-4-hydroxy-1-buten-3-ones and esters thereof
Hoffmann et al. Chiral organometallic reagents. Part XXV. 1 The stereochemistry of the ring opening of cyclopropylallyllithium compounds
JP4024645B2 (en) Process for producing triarylphosphoniophenolate
US4323711A (en) Process for producing cyclohexenes
JPS582206B2 (en) Carbon-carbon bond method
Gebhard et al. Synthesis of retinals labelled with 13C in the cyclohexene ring
Browne et al. Studies in the cyclopropa-arene series: cyclopropa [b] naphthalenes
US4268453A (en) Process for the manufacture of cholestene derivatives and novel intermediates in their manufacture
JPS6219427B2 (en)
US4124648A (en) Process for the preparation of norpatchoulenol and intermediates therefor